PRISM 2 project
Precision medicine for psychiatry:
From brain function to behaviour
About PRISM 2
Our Vision
Currently, neuropsychiatric disorders are largely diagnosed and treated with symptom-based approaches, lacking reference to quantitative biological underpinnings. This weakness impedes both innovative drug development and effective treatment. The preceding PRISM project has successfully identified quantitative neurobiological parameters related to Schizophrenia (SZ), Alzheimer’s Disease (AD), and to social function irrespective of diagnosis. PRISM 2 builds on PRISM outcomes and has three objectives. First, to determine the reproducibility of the transdiagnostic and pathophysiological relationship between default mode network (DMN) integrity and social dysfunction in SZ and AD and determine its potential to generalise to Major Depressive Disorder (MDD). Second, to test the causality between the quantitative variation in DMN integrity and social dysfunction. And third, to implement project results to the benefit of patients and health care providers. Our vision is that in the future every psychiatric patient receives the most accurate diagnosis and best possible treatment based on precise quantitative technologies and a deeper biological understanding of these brain disorders.
Certain behavioural phenomena, such as social dysfunction, are common across various psychiatric and neurological disorders. Social withdrawal from established social networks, colleagues, or friends, for example, is one of the earliest symptoms seen in patients with Alzheimer’s Disease (AD), Schizophrenia (SZ), or Major Depressive Disorder (MDD), and appears to be an early indicator of cognitive deficits. In the clinical study of the PRISM 2 project, patients will be recruited and assessed on two separate days, including screening and clinical interviews, completion of questionnaires, blood sampling, use of a new smartphone app (a product of the PRISM project), as well as electroencephalogram (EEG) and functional magnetic resonance imaging (fMRI) procedures. With these measurements, we aim to better understand the biological reasons for these severely impairing neuro-psychiatric diseases, improve diagnosis, and accelerate the development of new treatments. In total, we hope to recruit about 160 study participants. With these efforts, the PRISM 2 consortium is determined to exert a positive impact on public mental health and well-being.
Professor Martien Kas is interviewed by Tom Parkhill (ECNP). Professor Kas is the PRISM academic project coordinator and Professor of Behavioural Neuroscience at the University of Groningen.
The interview gives some background information on PRISM and explains the goals for PRISM 2.
The Kick-off Meeting took place online from 22-23 June 2021 and was a full success. We can’t wait to see everyone in person again during the project’s first face-to-face meeting once there are no more travel restrictions due to the pandemic.
We use cookies to improve your experience. Until you consent, only those cookies necessary to maintain the website's basic functionality are active. Website features, security and statistics are best if you activate "All cookies" (incl. Twitter, YouTube, Google reCAPTCHA and Google Analytics). You can revoke your choice at any time. Just clear your browser cache and update your settings. Please also view our Privacy Policy.
Functional cookies only
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistical cookies
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
All cookies
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
